Page last updated: 2024-10-23

aspirin and Asystole

aspirin has been researched along with Asystole in 32 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
"The Cardiac Arrhythmia Suppression Trial (CAST) was a multicenter double-blind, placebo-controlled study designed to determine whether suppression of ventricular ectopic activity by means of antiarrhythmic drugs (encainide, flecainide or moricizine) after acute myocardial infarction would reduce the incidence of arrhythmic death."9.07Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). ( Barker, AH; Brooks, MM; Capone, R; Echt, DS; Greene, HL; Liebson, PR; Mitchell, LB; Peters, RW, 1994)
"Comatose survivors of out of hospital cardiac arrest were included and divided into two groups, depending on whether dual platelet inhibition with peroral ticagrelor and aspirin was given or not."7.80Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study. ( Dankiewicz, J; Friberg, H; Kander, T; Schött, U, 2014)
"The Cardiac Arrhythmia Suppression Trial (CAST) was a multicenter double-blind, placebo-controlled study designed to determine whether suppression of ventricular ectopic activity by means of antiarrhythmic drugs (encainide, flecainide or moricizine) after acute myocardial infarction would reduce the incidence of arrhythmic death."5.07Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). ( Barker, AH; Brooks, MM; Capone, R; Echt, DS; Greene, HL; Liebson, PR; Mitchell, LB; Peters, RW, 1994)
" Samter's triad consists of nasal polyps, asthma, and aspirin (or nonsteroidal anti-inflammatory drug) sensitivity."3.83A Case of Kounis Type I in a Young Woman With Samter's Triad. ( Chou, A; Rayner-Hartley, E; Saw, J; Sedlak, T, 2016)
" We present the case of a 50-year-old male with the Samter-Beer triad of asthma, nasal polyps, and salicylate intolerance with an ST elevation myocardial infarction complicated with cardiac arrest due to multi-vessel coronary artery spasm secondary to aspirin anaphylaxis."3.81Kounis syndrome with Samter-Beer triad treated with intracoronary adrenaline. ( Ihdayhid, AR; Rankin, J, 2015)
"Comatose survivors of out of hospital cardiac arrest were included and divided into two groups, depending on whether dual platelet inhibition with peroral ticagrelor and aspirin was given or not."3.80Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study. ( Dankiewicz, J; Friberg, H; Kander, T; Schött, U, 2014)
"Infectious mononucleosis is a common viral illness of adolescence."2.48Spontaneous splenic rupture in infectious mononucleosis: case report and review of the literature. ( Pomerantz, WJ; Rinderknecht, AS, 2012)
"Up to 90% of cardiac arrests are due to acute myocardial infarction or severe myocardial ischaemia."1.35Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction. ( Arntz, HR; Breckwoldt, J; Dissmann, R; Marschalk, A; Müller, D; Wenzel, V, 2008)
" After controlling for age, prehospital dosage of epinephrine, and the duration of cardiac arrest we found a non significant trend towards good neurological recovery when thrombolytic therapy was given (OR 1."1.31Thrombolytic therapy after cardiac arrest and its effect on neurological outcome. ( Gabriel, D; Holzer, M; Kuerkciyan, I; Laggner, AN; Muellner, M; Schreiber, W; Sterz, F, 2002)
"Concomitant drug therapies after sudden cardiac arrest and their potential effect of altering heart rate variability (HRV) represent confounding factors in interpreting the outcome of nonpharmacologic therapies on HRV."1.29Description of time- and frequency- domain-based measures of heart rate variability in individuals taking antiarrhythmics, beta blockers, calcium channel blockers, and/or antihypertensive drugs after sudden cardiac arrest. ( Burr, RL; Cain, KC; Cowan, MJ; Narayanan, SB; Pike, K, 1993)

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19906 (18.75)18.7374
1990's3 (9.38)18.2507
2000's7 (21.88)29.6817
2010's14 (43.75)24.3611
2020's2 (6.25)2.80

Authors

AuthorsStudies
Siegel, AJ2
Liu, H1
Li, J1
Chen, M1
Yang, T1
Ruan, Z1
Su, J1
Xing, Y1
Varol, S1
Şahin, İ1
Kum, G1
Katkat, F1
Okuyan, E1
Buitrago, I2
Wolinsky, D2
Asher, CR1
Alraies, MC1
Asher, C1
Kander, T1
Dankiewicz, J1
Friberg, H1
Schött, U1
Ihdayhid, AR1
Rankin, J1
Singletary, EM1
Zideman, DA1
De Buck, ED1
Chang, WT1
Jensen, JL1
Swain, JM1
Woodin, JA1
Blanchard, IE1
Herrington, RA1
Pellegrino, JL1
Hood, NA1
Lojero-Wheatley, LF1
Markenson, DS1
Yang, HJ1
Rayner-Hartley, E1
Chou, A1
Saw, J1
Sedlak, T1
Horn, P1
Pasch, A1
Maxhera, B1
Kelm, M1
Westenfeld, R1
Yanagawa, Y1
Omori, K1
Takeuchi, I1
Jitsuiki, K1
Yoshizawa, T1
Ishikawa, K1
Kando, Y1
Fukata, M1
Ohsaka, H1
García Paredes, T1
Escudero Varela, JC1
Mora Ordóñez, JM1
Avlonitis, VS1
Planas, S1
Hayes, AM1
Parry, A1
Rinderknecht, AS1
Pomerantz, WJ1
Seniuk, W1
Mularek-Kubzdela, T1
Grygier, M1
Grajek, S1
Cieśliński, A1
SoRelle, R1
BEVERIDGE, GW1
FORSHALL, W1
MUNRO, JF1
OWEN, JA1
WESTON, IA1
Hwong, TM1
Arifi, AA1
Wan, IY1
Thung, KH1
Wan, S1
Sung, RY1
Yim, AP1
Arntz, HR1
Wenzel, V1
Dissmann, R1
Marschalk, A1
Breckwoldt, J1
Müller, D1
Leffert, RL1
Hackett, RL1
Gross, F1
Cowan, MJ1
Pike, K1
Burr, RL1
Cain, KC1
Narayanan, SB1
Peters, RW1
Mitchell, LB1
Brooks, MM1
Echt, DS1
Barker, AH1
Capone, R1
Liebson, PR1
Greene, HL1
Matsuno, N1
Muto, S1
Uchiyama, M1
Kozaki, K1
Kageyama, T1
Suzuki, T1
Kozaki, M1
Nagao, T1
Schreiber, W1
Gabriel, D1
Sterz, F1
Muellner, M1
Kuerkciyan, I1
Holzer, M1
Laggner, AN1
Ryan, WA1
Roden, VJ1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Long Term Safety Study in Patients Included in the CLARINET Study With Cyanotic Congenital Heart Disease Palliated With a Systemic-to-pulmonary Artery Shunt and for Whom the Shunt is Still in Place at One Year of Age[NCT00833703]Phase 349 participants (Actual)Interventional2009-01-31Completed
[NCT00000526]Phase 30 participants Interventional1986-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants According to Bleeding Type/Etiology

For all reported bleeding events, the type and the etiology of the bleeding event were collected. Participants who experienced bleeding events during the 'on-treatment period' were counted by bleeding type and etiology. (NCT00833703)
Timeframe: Up to a maximum of 6 months

,
Interventionparticipants (Number)
SpontaneousPuncture (vascular access site)
Clopidogrel 0.2 mg/kg/Day11
Placebo00

Number of Participants With Bleeding Events

"All bleeding events experienced during the study period were collected as for any Adverse Event.~The 'on-treatment' period was defined as the period from inclusion in the extension study up to 28 days after treatment discontinuation, and participants who experienced bleeding events during that period were counted." (NCT00833703)
Timeframe: Up to a maximum of 6 months

,
Interventionparticipants (Number)
Any bleeding event- Serious- Serious with an outcome of death- Leading to permanent treatment discontinuation
Clopidogrel 0.2 mg/kg/Day2000
Placebo0000

Number of Participants With Shunt Thrombosis Requiring Intervention or Deaths

"Outcome events, shunt thrombosis requiring intervention or death, experienced during the study period were recorded.~Participants were counted excluding the events that occured after the participant's protocol study end (occurrence of shunt thrombosis, next surgical procedure for correction of the congenital heart disease, death, or 18 months of age, whichever came first)." (NCT00833703)
Timeframe: Up to a maximum of 6 months

,
Interventionparticipants (Number)
shunt thrombosis requiring interventiondeath
Clopidogrel 0.2 mg/kg/Day00
Placebo01

Reviews

3 reviews available for aspirin and Asystole

ArticleYear
A Meta-Analysis of Randomized and Observational Studies: Aspirin Protects from Cardiac Surgery-Associated Acute Kidney Injury.
    The heart surgery forum, 2019, 07-25, Volume: 22, Issue:4

    Topics: Acute Kidney Injury; Aspirin; Cause of Death; Coma; Coronary Artery Bypass; Heart Arrest; Heart Bloc

2019
Part 9: First Aid: 2015 International Consensus on First Aid Science With Treatment Recommendations.
    Circulation, 2015, Oct-20, Volume: 132, Issue:16 Suppl 1

    Topics: Airway Management; Aspirin; Asthma; Cardiopulmonary Resuscitation; Chest Pain; Emergencies; Emergenc

2015
Spontaneous splenic rupture in infectious mononucleosis: case report and review of the literature.
    Pediatric emergency care, 2012, Volume: 28, Issue:12

    Topics: Abdominal Pain; Adolescent; Air Ambulances; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants;

2012

Trials

1 trial available for aspirin and Asystole

ArticleYear
Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST).
    Journal of the American College of Cardiology, 1994, Volume: 23, Issue:2

    Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Aspirin; Circadian Rhythm; Death, Sudden, Cardia

1994

Other Studies

28 other studies available for aspirin and Asystole

ArticleYear
Pre-Race Aspirin to Enhance Primary Prevention of Marathon-Related Cardiac Arrest: Confronting Pheidippides' Legacy.
    The American journal of medicine, 2023, Volume: 136, Issue:7

    Topics: Aspirin; Death, Sudden, Cardiac; Heart Arrest; Humans; Marathon Running; Primary Prevention

2023
Coronary stent embolism to the right posterior cerebral artery.
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2020, Volume: 48, Issue:3

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Atropine; Clopidogrel; Coronary Angiography; Coronary Arter

2020
Aspirin Use to Reduce the Risk of Sports-Related Cardiac Arrest in High-Risk Athletes.
    The American journal of medicine, 2019, Volume: 132, Issue:3

    Topics: Aspirin; Athletes; Heart; Heart Arrest; Humans; Sports

2019
Syncope during a pharmacologic nuclear stress test.
    Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:5

    Topics: Adenosine; Aspirin; Aspirin, Dipyridamole Drug Combination; Dipyridamole; Drug Combinations; Drug In

2014
A serious complication of a common stress test (May 2014).
    Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:7

    Topics: Adenosine; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Platelet Aggregation Inhibitors; Rad

2014
In reply.
    Cleveland Clinic journal of medicine, 2014, Volume: 81, Issue:7

    Topics: Adenosine; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Platelet Aggregation Inhibitors; Rad

2014
Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational study.
    Critical care (London, England), 2014, Sep-30, Volume: 18, Issue:5

    Topics: Adenosine; Adult; Aged; Aspirin; Blood Platelets; Coma; Combined Modality Therapy; Drug Therapy, Com

2014
Kounis syndrome with Samter-Beer triad treated with intracoronary adrenaline.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2015, Nov-15, Volume: 86, Issue:6

    Topics: Anaphylaxis; Aspirin; Asthma; Chest Pain; Coronary Stenosis; Coronary Vessels; Electrocardiography;

2015
A Case of Kounis Type I in a Young Woman With Samter's Triad.
    The Canadian journal of cardiology, 2016, Volume: 32, Issue:10

    Topics: Acute Coronary Syndrome; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma, Aspirin-Induced;

2016
When extracorporeal CPR fails-fatal ionized hypocalcemia during cardiac arrest.
    The American journal of emergency medicine, 2016, Volume: 34, Issue:11

    Topics: Adult; Aspirin; Drug Overdose; Extracorporeal Membrane Oxygenation; Fatal Outcome; Female; Heart Arr

2016
Cardiac arrest at high elevation with a favorable outcome.
    The American journal of emergency medicine, 2017, Volume: 35, Issue:4

    Topics: Adult; Air Ambulances; Altitude; Aspirin; Computed Tomography Angiography; Coronary Angiography; Cor

2017
How do aspirin and nitroglycerin differ in heart attack prevention and treatment?
    Heart advisor, 2009, Volume: 12, Issue:1

    Topics: Aspirin; Heart Arrest; Humans; Nitroglycerin; Vasodilator Agents

2009
[Non-occlusive stent thrombosis associated to cardiocirculatory arrest].
    Medicina intensiva, 2010, Volume: 34, Issue:2

    Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Restenosi

2010
Occlusion of modified Blalock-Taussig shunt after clopidogrel cessation.
    The Annals of thoracic surgery, 2012, Volume: 93, Issue:2

    Topics: Anticoagulants; Aspirin; Blalock-Taussig Procedure; Clopidogrel; Fatal Outcome; Graft Occlusion, Vas

2012
Cardiac arrest related to coronary spasm in patients with variant angina: a three-case study.
    Journal of internal medicine, 2002, Volume: 252, Issue:4

    Topics: Amiodarone; Angina Pectoris, Variant; Anti-Arrhythmia Agents; Aspirin; Calcium Channel Blockers; Car

2002
Percutaneous intervention a winner--even in patients with stable, single-vessel disease.
    Circulation, 2003, Sep-16, Volume: 108, Issue:11

    Topics: Angioplasty, Balloon, Coronary; Aspirin; Congresses as Topic; Contraindications; Coronary Artery Dis

2003
ACUTE SALICYLATE POISONING IN ADULTS.
    Lancet (London, England), 1964, Jun-27, Volume: 2, Issue:7348

    Topics: Acute Kidney Injury; Aspirin; Blood Chemical Analysis; Bronchopneumonia; Coma; Diagnosis, Differenti

1964
Rupture of a giant coronary artery aneurysm due to Kawasaki disease.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:2

    Topics: Anticoagulants; Aspirin; Cardiac Tamponade; Child, Preschool; Combined Modality Therapy; Coronary An

2004
Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction.
    Resuscitation, 2008, Volume: 76, Issue:2

    Topics: Aspirin; Cardiopulmonary Resuscitation; Drug Therapy, Combination; Emergency Medical Services; Femal

2008
Aspergillus aortitis following replacement of aortic valve.
    The Journal of thoracic and cardiovascular surgery, 1967, Volume: 53, Issue:6

    Topics: Adult; Aortic Diseases; Aspergillus; Aspirin; Cardiac Catheterization; Cephalothin; Extracorporeal C

1967
[Infarction prophylaxis--prevention of the sudden heart death? An alternative].
    MMW, Munchener medizinische Wochenschrift, 1982, May-07, Volume: 124, Issue:18

    Topics: Adrenergic beta-Antagonists; Anticoagulants; Aspirin; Dipyridamole; Female; Heart Arrest; Humans; Ma

1982
Description of time- and frequency- domain-based measures of heart rate variability in individuals taking antiarrhythmics, beta blockers, calcium channel blockers, and/or antihypertensive drugs after sudden cardiac arrest.
    Journal of electrocardiology, 1993, Volume: 26 Suppl

    Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antihypertensive Agents; Aspirin; Calcium Chann

1993
Beneficial effect of aspirin and protease inhibitor as graft conditioning using machine perfusion in warm ischemically injured kidneys.
    Transplantation proceedings, 1997, Volume: 29, Issue:8

    Topics: Animals; Aspirin; Creatinine; Dogs; Graft Survival; Heart Arrest; Humans; Kidney; Kidney Transplanta

1997
Thrombolytic therapy after cardiac arrest and its effect on neurological outcome.
    Resuscitation, 2002, Volume: 52, Issue:1

    Topics: Aged; Aspirin; Cardiopulmonary Resuscitation; Case-Control Studies; Cerebrovascular Circulation; Con

2002
Overview of American Heart Association protocols. Part 2--A.C.L.S.
    Texas dental journal, 2000, Volume: 117, Issue:6

    Topics: Adult; Advanced Cardiac Life Support; Algorithms; American Heart Association; Analgesics, Opioid; An

2000
Medical controversy: does an aspirin a day keep heart attacks away?
    Dental School quarterly, 1988, Volume: 4, Issue:2

    Topics: Adult; Aspirin; Heart Arrest; Humans; Male

1988
Aspirin: a dangerous pulmonary foreign body.
    The Journal of pediatrics, 1973, Volume: 83, Issue:2

    Topics: Aspirin; Child, Preschool; Female; Foreign Bodies; Heart Arrest; Humans; Infant; Inhalation; Male; R

1973
Polycythemia vera complicated by acute leukemia and a rapidly enlarging mass in the left upper abdominal quadrant.
    The American journal of medicine, 1967, Volume: 42, Issue:6

    Topics: Aspirin; Female; Heart Arrest; Humans; Leukemia, Myeloid; Metaraminol; Middle Aged; Polycythemia Ver

1967